Innate Pharma to participate in upcoming investor conferences

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conferences:  

• SVB Securities Global Biopharma Conference 
Event Date: February 14 - 16, 2023 (virtual)

• Citi's 2023 Virtual Oncology Leadership Summit
Event Date: February 22, 2023 (virtual)

• H.C. Wainwright Cell Therapy Virtual Conference
Event Date: February 28, 2023 (virtual)